Speranza Rubattu Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

11/2021

Trehalose, a natural disaccharide, reduces stroke occurrence in the stroke-prone spontaneously hypertensive rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Speranza Rubattu Research Topics

Disease

33	Stroke (Strokes) 02/2024 - 11/2002
33	Hypertension (High Blood Pressure) 01/2024 - 11/2002
22	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2006
21	Heart Failure 02/2024 - 11/2002
8	Mitochondrial Diseases (Mitochondrial Disease) 02/2024 - 12/2014
7	Acute Coronary Syndrome 01/2022 - 05/2012
6	Coronary Artery Disease (Coronary Atherosclerosis) 03/2023 - 09/2009
6	Ischemic Stroke 05/2022 - 04/2004
6	Inflammation (Inflammations) 01/2017 - 03/2009
5	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 03/2023 - 01/2006
5	Atrial Fibrillation 03/2023 - 01/2013
5	Myocardial Infarction 11/2021 - 11/2002
5	Atherosclerosis 11/2021 - 09/2009
5	Vascular Diseases (Vascular Disease) 10/2021 - 04/2004
3	Cardiomyopathies (Cardiomyopathy) 08/2023 - 09/2009
3	Fibrosis (Cirrhosis) 01/2023 - 11/2013
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 05/2020 - 01/2010
3	Stable Angina 01/2019 - 05/2012
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2018 - 08/2016
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 10/2004
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2009 - 04/2007
2	Hypertrophy 02/2024 - 01/2023
2	Neoplasms (Cancer) 08/2023 - 01/2015
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2023 - 01/2010
2	Infarction (Infarctions) 01/2023 - 01/2018
2	Disease Progression 01/2022 - 11/2019
2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 11/2019
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021 - 08/2010
2	COVID-19 01/2021 - 01/2020
2	Ventricular Tachycardia 06/2015 - 12/2013
2	Essential Hypertension 06/2015 - 08/2006
2	Cardiomegaly (Heart Hypertrophy) 12/2014 - 01/2010
2	Vascular Remodeling 09/2009 - 01/2007
2	Obesity 07/2008 - 04/2007
1	Heart Valve Diseases (Valvular Heart Disease) 03/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Ischemia 01/2023
1	Metabolic Diseases (Metabolic Disease) 01/2022

Drug/Important Bio-Agent (IBA)

29	Atrial Natriuretic Factor (ANF)IBA 04/2023 - 02/2004
20	Natriuretic PeptidesIBA 01/2023 - 04/2004
12	SaltsIBA 02/2024 - 10/2006
11	Proteins (Proteins, Gene)FDA Link 03/2023 - 11/2009
8	Biomarkers (Surrogate Marker)IBA 03/2023 - 11/2010
8	Uncoupling Protein 2IBA 05/2022 - 02/2013
7	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2023 - 09/2009
6	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 09/2009
5	AntioxidantsIBA 01/2024 - 02/2013
5	PotassiumIBA 01/2017 - 10/2006
4	Neprilysin (Neutral Endopeptidase)IBA 03/2023 - 06/2013
3	TrehaloseIBA 11/2023 - 01/2018
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2023 - 11/2004
3	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 09/2012
3	Messenger RNA (mRNA)IBA 01/2022 - 08/2015
3	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2021 - 01/2018
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 02/2016
3	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2019 - 08/2006
3	NADPH Oxidases (NAD(P)H oxidase)IBA 02/2017 - 08/2003
2	SphingolipidsIBA 01/2024 - 04/2021
2	Niacinamide (Nicotinamide)FDA LinkGeneric 11/2023 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2023 - 10/2016
2	AngiotensinsIBA 01/2023 - 11/2009
2	ReninIBA 01/2023 - 11/2009
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 12/2014
2	Angiotensin Receptor AntagonistsIBA 01/2022 - 06/2013
2	CalciumIBA 01/2022 - 12/2013
2	DisaccharidesIBA 11/2021 - 01/2018
2	Hormones (Hormone)IBA 01/2021 - 01/2006
2	ResveratrolIBA 11/2020 - 01/2015
2	erucylphosphocholineIBA 01/2020 - 10/2016
2	Beclin-1IBA 01/2020 - 01/2018
2	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2020 - 01/2019
2	N-terminal proatrial natriuretic peptideIBA 11/2019 - 04/2007
2	SodiumIBA 01/2017 - 07/2015
2	Vasodilator Agents (Vasodilators)IBA 02/2014 - 01/2006
2	DiureticsIBA 02/2014 - 01/2006
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2013 - 11/2002
1	Angiotensin IIIBA 02/2024
1	Adrenergic Agents (Adrenergic Drugs)IBA 02/2024
1	Endothelin-1 (Endothelin 1)IBA 02/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2024
1	naringeninIBA 02/2024
1	SolutionsIBA 01/2024
1	Plant ExtractsIBA 01/2024
1	SpermidineIBA 11/2023
1	PolyphenolsIBA 11/2023
1	Sirtuin 3IBA 08/2023
1	ConnectinIBA 03/2023
1	AldosteroneIBA 01/2023
1	TriazolesIBA 01/2023
1	NADH DehydrogenaseIBA 01/2023
1	peptide AIBA 01/2023
1	N-propionylprocainamideIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2022
1	Stromal Interaction Molecule 1IBA 01/2022
1	vericiguatIBA 11/2021

Therapy/Procedure

8	Therapeutics 01/2022 - 07/2014
3	Percutaneous Coronary Intervention 10/2018 - 04/2016
2	Stents 10/2018 - 04/2016